Towards a High-fat Feeding Intervention Study: Identification of Markers for Inflammation and Organ Damage
1 other identifier
observational
24
1 country
1
Brief Summary
Patients undergoing major surgery, trauma or burns are prone to develop an exacerbated inflammatory response, which is potentially lethal to the individual. Recently, the researchers' group showed in a rodent model of hemorrhagic shock that high-fat feeding administered before shock attenuates inflammation and reduces intestinal and hepatic damage. In the mechanism that underlies this protective effect, the release of cholecystokinin in gut wall and activation of efferent vagus bundles are crucial events. Before investigating the effect of high-fat nutrition in clinical setting, suitable markers of inflammation and organ damage need to be selected. In this study, blood will be collected in patients undergoing different types of operations. Consequently several markers for inflammation and organ damage will be determined. Hence, suitable parameters for a future high-fat intervention study will be selected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 21, 2007
CompletedFirst Posted
Study publicly available on registry
August 22, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFebruary 24, 2017
March 1, 2010
1.8 years
August 21, 2007
February 22, 2017
Conditions
Keywords
Study Arms (3)
I
Liver surgery
II
Colon surgery
III
Femur Fracture
Interventions
In arterial or venous lines already present, small amounts of blood will be collected at certain timepoints following operation
Eligibility Criteria
Patients in Maastricht University Hospital area undergoing one of selected types of surgery
You may qualify if:
- \> 18 years
- elective liver / colon / femur surgery
You may not qualify if:
- Acute inflammation
- Chronic Obstructive Respiratory Disease
- Recent history of abdominal pain or diarrhea
- BMI \< 18.5
- Alcohol or Drugs abuses
- Recent intake of antibiotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Hospital
Maastricht, Limburg, 6229HX, Netherlands
Biospecimen
plasma
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan-Willem Greve, Professor
Maastricht University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 21, 2007
First Posted
August 22, 2007
Study Start
August 1, 2007
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
February 24, 2017
Record last verified: 2010-03